Obesity and persisting sleep apnea after adenotonsillectomy in Greek children

Maria T Apostolidou1, Emmanouel I Alexopoulos2, Konstantinos Chaidas2

  • 1Department of Otorhinolaryngology, University of Thessaly School of Medicine, Larissa, Greece.

Chest
|August 12, 2008
PubMed

Insights

Adenotonsillectomy (AT) effectively treats sleep-disordered breathing (SDB) in children, regardless of obesity. This study found no significant difference in SDB cure rates between obese and nonobese children after AT.

Area of Science:

  • Pediatric Otolaryngology
  • Sleep Medicine
  • Pediatric Pulmonology

Background:

  • The role of obesity versus adenotonsillar hypertrophy in childhood obstructive sleep-disordered breathing (SDB) is not fully understood.
  • Adenotonsillectomy (AT) is a common treatment for SDB, but its success rates can vary, particularly in obese children who may have residual disease postoperatively.

Purpose of the Study:

  • To evaluate the effectiveness of adenotonsillectomy (AT) as a treatment for sleep-disordered breathing (SDB) in both obese and nonobese children.

Main Methods:

  • Children with adenoidal/tonsillar hypertrophy undergoing AT for SDB had pre- and post-operative polysomnography.
  • Obesity was defined as a body mass index (BMI) z score > 1.645.
  • The primary outcome was the cure of SDB, defined as a postoperative obstructive apnea-hypopnea index (OAHI) < 1 episode/hour.

Main Results:

  • The study included 22 obese and 48 nonobese children.
  • Post-AT, the cure rates for SDB did not significantly differ between obese (22.7%) and nonobese (25%) children (p > 0.05).
  • Obesity, hypertrophy type, gender, and postoperative BMI changes were not significant predictors of SDB cure.

Conclusions:

  • Adenotonsillectomy (AT) demonstrates comparable efficacy in treating sleep-disordered breathing (SDB) in both obese and nonobese pediatric populations.
  • Obesity is not a predictor of poor outcomes following AT for SDB in children.
Abstract

Related Concept Videos

Sleep Apnea01:21

Sleep Apnea

Sleep apnea is a condition where breathing stops intermittently during sleep, often leading to significant health issues. Each episode can last from 10 to 20 seconds or more and is frequently accompanied by a brief arousal from sleep. This disturbance, largely unnoticed by the individual, can lead to severe daytime fatigue. Commonly, individuals seek help after being informed by their partners about loud snoring and noticeable breathing pauses during sleep.
The condition is more prevalent among...
Tonsillitis I: Introduction01:30

Tonsillitis I: Introduction

Tonsillitis is inflammation of the tonsils, which are two lymphoid tissue masses at the back of the throat. This condition can cause discomfort and irritation in the throat.
Etiology
Three primary contributing factors have been identified.
Chronic Pharyngitis01:23

Chronic Pharyngitis

Chronic pharyngitis refers to persistent inflammation of the pharyngial mucosa.
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Tonsillitis II: Management01:26

Tonsillitis II: Management

This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...